Resources
Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center
Annals of surgical oncology, Vol. 29, Issue 2, Pages 1423-1432, 2021
PMID: 34601666
The burden of hereditary breast cancer in India is not well defined. Moreover, genetic testing criteria (National Comprehensive Cancer Network [NCCN] and Mainstreaming Cancer Genetics [MCG] Plus) have never been validated in the Indian population.
https://www.ncbi.nlm.nih.gov/pubmed/34601666
Considering Genomic Research?
Company
Resources
Research
- Tumor Microenvironment Solutions
- Immune Profiling Services
- NGS Services
- BioFX Bioinformatics Services
- Antibody Discovery Services
Diagnostics
Contact
2025 © MedGenome • All Rights Reserved